Ex vivo gene therapy for hemophilia A that enhances safe delivery and sustained in vivo factor VIII expression from lentivirally engineered endothelial progenitors.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples